The knockdown of both GSK3α and GSK3β resulted in aggressive AML [92], although GSK3α deletion alone had no effect on hematopoiesis, and deletion of GSK3β resulted in myelodysplastic syndromes. Here, GSK3B is linked to acute myeloid leukemia.